Patents by Inventor Murray Lappe
Murray Lappe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9613182Abstract: A system, method, and computer program that may used to more quickly, accurately, and efficiently identify, catalog, and track human assay samples and create documentation with respect to the human assay samples.Type: GrantFiled: November 16, 2015Date of Patent: April 4, 2017Assignee: eScreen, Inc.Inventors: Murray Lappe, Brad Rein
-
Publication number: 20170008050Abstract: An integrated medical waste management and treatment system may include sensors, interlocks, communications links and/or other features for determining if the waste itself, the decontaminating disinfectant used in the process, or the status of the system are consistent with recommended or authorized system operation. System operation may be terminated if a condition inconsistent with recommended or authorized system operation is detected. Such compliance apparatus may include an electronic scale for determining the weight of the waste loaded into the receiver compartment, a metal detector, or a sensor for determining if the decontaminating disinfectant is a recommended or authorized disinfectant. A communications link may be provided to transmit information to a central station or to deliver updates or commands associated with the recommended or authorized operation of each system.Type: ApplicationFiled: July 18, 2016Publication date: January 12, 2017Inventors: Dwight Morgan, Murray Lappe
-
Publication number: 20160070865Abstract: A system, method, and computer program that may used to more quickly, accurately, and efficiently identify, catalog, and track human assay samples and create documentation with respect to the human assay samples.Type: ApplicationFiled: November 16, 2015Publication date: March 10, 2016Inventors: Murray Lappe, Brad Rein
-
Patent number: 9189602Abstract: A system, method, and computer program for more quickly, accurately, and efficiently identifying, cataloging, and tracking human assay samples and creating documentation with respect to the human assay samples. The computer program and method include the steps of: storing donor information in a donor information database accessible by a computer; storing client information in a client information database accessible by the computer; retrieving client information necessary to determine a type of test to be performed on a specimen; storing collection facility information in a collection facility database accessible by the computer; administering a human analyte test using the computer program to guide a collector of the specimen and identify problematic exceptions; receiving the test result electronically and storing the result in a test result database accessible by the computer; and permitting authorized persons to electronically access the test result via a communications network.Type: GrantFiled: May 23, 2012Date of Patent: November 17, 2015Assignee: eScreen, Inc.Inventors: Murray Lappe, Brad Rein
-
Publication number: 20120284042Abstract: A system, method, and computer program for more quickly, accurately, and efficiently identifying, cataloging, and tracking human assay samples and creating documentation with respect to the human assay samples. The computer program and method include the steps of: storing donor information in a donor information database accessible by a computer; storing client information in a client information database accessible by the computer; retrieving client information necessary to determine a type of test to be performed on a specimen; storing collection facility information in a collection facility database accessible by the computer; administering a human analyte test using the computer program to guide a collector of the specimen and identify problematic exceptions; receiving the test result electronically and storing the result in a test result database accessible by the computer; and permitting authorized persons to electronically access the test result via a communications network.Type: ApplicationFiled: May 23, 2012Publication date: November 8, 2012Applicant: eScreen, Inc.Inventors: Murray Lappe, Brad Rein
-
Patent number: 8200438Abstract: A system, method, and computer program that quickly, accurately, and efficiently identifies, catalogs, and tracks human assay samples and creates documentation for the human assay samples. The computer program and method include the steps of: storing donor information in a donor information database accessible by a computer; storing client information in a client information database accessible by the computer; retrieving client information necessary to determine a type of test to be performed on a specimen; storing collection facility information in a collection facility database accessible by the computer; administering a human analyte test using the computer program to guide a collector of the specimen and identify problematic exceptions; receiving the test result electronically and storing the result in a test result database accessible by the computer; and permitting the client, Medical Review Officer, and other authorized persons to electronically access the test result via a communications network.Type: GrantFiled: August 19, 2002Date of Patent: June 12, 2012Assignee: eScreen, Inc.Inventors: Murray Lappe, Brad Rein
-
Patent number: 8024148Abstract: Systems and methods for end-of-life disabling of a diagnostic test system are described. In one aspect, a diagnostic test system that includes a test unit and a disabling unit. The test unit performs at least one diagnostic test on a diagnostic assay to determine whether at least one analyte is present within a sample. The disabling unit determines a measure of current lifetime of the test unit and disables the test unit in response to a determination that the current lifetime measure meets an end-of-life threshold. In a diagnostic test method, at least one diagnostic test is performed on a diagnostic assay to determine whether at least one analyte is present within a sample. A measure of current lifetime of the test unit is determined. The test unit is disabled in response to a determination that the current lifetime measure meets an end-of-life threshold.Type: GrantFiled: January 22, 2007Date of Patent: September 20, 2011Assignee: Alverix, Inc.Inventors: Patrick T. Petruno, Murray Lappe
-
Patent number: 7943381Abstract: A system for automatically testing a fluid specimen, e.g., urine, to indicate the presence of specified chemical components in the specimen. The system preferably utilizes an assaying device comprised of a collection cup and a cap which carries at least one test strip. The device includes an integrated aliquot delivery mechanism actuatable to wet the test strip with an aliquot delivered from the fluid specimen. The assaying device is configured to operate in conjunction with an electronic reader device capable of actuating the aliquot delivery mechanism and reading the reaction of the test strip. A preferred reader device defines a keyed receptacle for accommodating a complementary shaped cup housing in a particular orientation. The reader device is comprised of a camera for capturing the image of a test strip, an actuator for actuating an aliquot delivery mechanism, and a microprocessor/controller for (1) controlling the camera and actuator and (2) processing the image.Type: GrantFiled: October 27, 2006Date of Patent: May 17, 2011Assignee: eScreen, Inc.Inventors: Murray Lappe, David A. Birkner, John Goodin, Keith Patten, Bill Whitford
-
Publication number: 20080028261Abstract: Systems and methods for end-of-life disabling of a diagnostic test system are described. In one aspect, a diagnostic test system that includes a test unit and a disabling unit. The test unit performs at least one diagnostic test on a diagnostic assay to determine whether at least one analyte is present within a sample. The disabling unit determines a measure of current lifetime of the test unit and disables the test unit in response to a determination that the current lifetime measure meets an end-of-life threshold. In a diagnostic test method, at least one diagnostic test is performed on a diagnostic assay to determine whether at least one analyte is present within a sample. A measure of current lifetime of the test unit is determined. The test unit is disabled in response to a determination that the current lifetime measure meets an end-of-life threshold.Type: ApplicationFiled: January 22, 2007Publication date: January 31, 2008Inventors: Patrick Petruno, Murray Lappe
-
Publication number: 20070298436Abstract: A machine readable assaying system comprising a test card having machine readable assaying means. A plurality of individual analysis strips, each strip comprising antibodies and/or reagents capable of indicating the positive presence of distinct illicit substances form a pattern of elements including one or more fixed strips and one or more blank regions. The detection of the presence of a particular substance or drug will result in one or more of the analysis strips changing from a first (light reflective) color to a second darker (light absorbent) color. The pattern of analysis strips, fixed strips and blank regions may be provided to encode one or more characters/digits of information. By the inclusion of the analysis strips with the plurality of fixed strips and blank regions, the detection of one or more illicit substances may alter the overall pattern of fixed and test strips and blank regions, and hence cause the encoded information represented thereby to be altered.Type: ApplicationFiled: August 27, 2007Publication date: December 27, 2007Inventor: Murray Lappe
-
Publication number: 20070048875Abstract: A system for automatically testing a fluid specimen, e.g., urine, to indicate the presence of specified chemical components in the specimen. The system preferably utilizes an assaying device comprised of a specimen container having a unique identifier thereon and a cap which carries at least one test strip. A method for testing and controlling a custody of the specimen comprises obtaining a specimen from a donor, wherein the specimen is obtained at a service site; storing the specimen in the specimen container; performing a test on the specimen using a reader device in communication with a computer, wherein the test is performed at the service site; providing an electronic chain of custody form that controls a chain of custody procedure for the specimen; and allowing the donor to sign the electronic chain of custody form at the service site by signinig an electronic signature pad.Type: ApplicationFiled: October 27, 2006Publication date: March 1, 2007Applicant: eScreen, Inc.Inventors: Murray Lappe, David Birkner, John Goodin, Keith Patten, Bill Whitford
-
Publication number: 20070048184Abstract: A system for testing a plurality of test specimens, e.g., urine, to indicate the presence of specified chemical components in the specimen. The system preferably utilizes a testing device for local testing of the specimen at a service site. The system further includes a computer located at the service site and operable to receive test results obtained by the testing device. The computer then uploads the test result to a host computer remote from the service site. The host computer is in communication with a plurality of computers located at a plurality of service sites.Type: ApplicationFiled: October 27, 2006Publication date: March 1, 2007Applicant: eScreen, Inc.Inventors: Murray Lappe, David Birkner, John Goodin, Keith Patten, Bill Whitford
-
Publication number: 20050214865Abstract: A machine readable assaying system comprising a test card having machine readable assaying means. A plurality of individual analysis strips, each strip comprising antibodies and/or reagents capable of indicating the positive presence of distinct illicit substances form a pattern of elements including one or more fixed strips and one or more blank regions. The detection of the presence of a particular substance or drug will result in one or more of the analysis strips changing from a first (light reflective) color to a second darker (light absorbent) color. The pattern of analysis strips, fixed strips and blank regions may be provided to encode one or more characters/digits of information. By the inclusion of the analysis strips with the plurality of fixed strips and blank regions, the detection of one or more illicit substances may alter the overall pattern of fixed and test strips and blank regions, and hence cause the encoded information represented thereby to be altered.Type: ApplicationFiled: February 23, 2005Publication date: September 29, 2005Inventor: Murray Lappe
-
Publication number: 20050074362Abstract: A system for automatically testing a fluid specimen, e.g., urine, to indicate the presence of specified chemical components in the specimen. The system preferably utilizes an assaying device comprised of a collection cup and a cap which carries at least one test strip. The device includes an integrated aliquot delivery mechanism actuatable to wet the test strip with an aliquot delivered from the fluid specimen. The assaying device is configured to operate in conjunction with an electronic reader device capable of actuating the aliquot delivery mechanism and reading the reaction of the test strip. A preferred reader device defines a keyed receptacle for accommodating a complementary shaped cup housing in a particular orientation. The reader device is comprised of a camera for capturing the image of a test strip, an actuator for actuating an aliquot delivery mechanism, and a microprocessor/controller for (1) controlling the camera and actuator and (2) processing the image.Type: ApplicationFiled: September 30, 2004Publication date: April 7, 2005Inventors: Murray Lappe, David Birkner, John Goodin, Keith Patten, Bill Whitford
-
Publication number: 20040033501Abstract: A system, method, and computer program that may used to more quickly, accurately, and efficiently identify, catalog, and track human assay samples and create documentation with respect to the human assay samples.Type: ApplicationFiled: August 19, 2002Publication date: February 19, 2004Applicant: E-SCREEN, INC.Inventors: Murray Lappe, Brad Rein
-
Patent number: 6623979Abstract: A method and apparatus for collecting a fluid specimen, locally analyzing the specimen to qualitatively detect specified chemical components at concentrations above threshold levels, and providing machine readable test results for facilitating data collection and reporting. The apparatus includes an assaying device comprised of a cup for collecting a fluid specimen and a cap carrying at least one test strip for visually reacting to one or more specified chemical components in the specimen. The cap also carries an aliquot delivery mechanism for forcing an aliquot of the fluid specimen onto the test strip. The assaying device is preferably configured to interact with a reader device capable of reading the reaction of the test strip to produce a data output.Type: GrantFiled: October 4, 2001Date of Patent: September 23, 2003Assignee: EscreenInventors: Murray Lappe, John W. Goodin, Keith Patten, Bill Whitford
-
Patent number: 6616894Abstract: A method and apparatus for collecting a fluid specimen, locally analyzing the specimen to qualitatively detect specified chemical components at concentrations above threshold levels, and providing machine readable test results for facilitating data collection and reporting. The apparatus includes an assaying device comprised of a cup for collecting a fluid specimen and a cap carrying at least one test strip for visually reacting to one or more specified chemical components in the specimen. The cap also carries an aliquot delivery mechanism for forcing an aliquot of the fluid specimen onto the test strip. The assaying device is preferably configured to interact with a reader device capable of reading the reaction of the test strip to produce a data output.Type: GrantFiled: October 4, 2001Date of Patent: September 9, 2003Assignee: Screen, Inc.Inventors: Murray Lappe, John W. Goodin, Keith Patten, Bill Whitford
-
Patent number: 6342183Abstract: A method and apparatus for collecting a fluid specimen, locally analyzing the specimen to qualitatively detect specified chemical components at concentrations above threshold levels, and providing machine readable test results for facilitating data collection and reporting. The apparatus includes an assaying device comprised of a cup for collecting a fluid specimen and a cap carrying at least one test strip for visually reacting to one or more specified chemical components in the specimen. The cap also carries an aliquot delivery mechanism for forcing an aliquot of the fluid specimen onto the test strip. The assaying device is preferably configured to interact with a reader device capable of reading the reaction of the test strip to produce a data output.Type: GrantFiled: February 5, 1999Date of Patent: January 29, 2002Assignee: EscreenInventors: Murray Lappe, John W. Goodin, Keith Patten, Bill Whitford
-
Patent number: RE39226Abstract: A machine readable assaying system including an assay card having a machine readable assaying indicia located upon a surface of the card. At least one analysis element is provided with the assaying indicia, and is capable of monitoring a parameter to detect and optically signal the presence or absence of a desired state. The analysis elements composing, at least in part, an assaying mechanism in the form a pattern of elements, generally additionally including at least one fixed element, and or at least one blank region.Type: GrantFiled: May 10, 2001Date of Patent: August 8, 2006Assignee: eScreen, Inc.Inventor: Murray Lappe
-
Patent number: RE38509Abstract: A machine readable assaying system comprising a test card having machine readable assaying means. A plurality of individual analysis strips, each strip comprising antibodies and/or reagents capable of indicating the positive presence of distinct illicit substances form a pattern of elements including one or more fixed strips and one or more blank regions. The detection of the presence of a particular substance or drug will result in one or more of the analysis strips changing from a first (light reflective) color to a second darker (light absorbent) color. The pattern of analysis strips, fixed strips and blank regions may be provided to encode one or more characters/digits of information. By the inclusion of the analysis strips with the plurality of fixed strips and blank regions, the detection of one or more illicit substances may alter the overall pattern of fixed and test strips and blank regions, and hence cause the encoded information represented thereby to be altered.Type: GrantFiled: July 26, 2001Date of Patent: May 4, 2004Assignee: eScreen, Inc.Inventor: Murray Lappe